LocationLocation:
Sutton
PositionPosition:
Cancer Therapeutics
Salary Details:Salary Details:
From £45,600 per annum
Contract:Contract:
Fixed term
External Advertising End DateAdvertising End Date:
18 May 2026

Key Information

Salary: Dependent on relevant Postdoctoral experience. Future progression is based on annual performance review. 

Duration of Contract: Fixed Term for 2 years

Hours per week: 35 hours per week (Full Time)

Location: Sutton

Closing Date: 18th of May, this role may close early if a high number of suitable applications have been received. 

This role is eligible for ICR Sponsorship.  If this is your first visa in the UK, support will be provided for costs associated with Visa application. If you are considering relocating to the UK, further information can be found here

Job Details

We have an opportunity for a talented and motivated Postdoctoral Training Fellow to join the Division of Cancer Therapeutics. The team has a role to accelerate the translation of ICR research into drug discovery programmes. The team delivers bespoke, hypothesis-driven data packages to support decision-making for launch of drug discovery projects. The teams dedicated resources, including biology, functional genomics, assay sciences, chemistry, and bioinformatics teams, will support joint project teams that combine the deep biological and therapeutic knowledge of ICR investigators with the validation and technical expertise of drug discovery scientists. Scientists in the team work closely with the Centre for Target Validation to validate and streamline robust, targets into drug discovery programmes in the ICR’s Centre for Cancer Drug Discovery or into collaborative programmes with external commercial therapy discovery partners. Also, working with the Centre for Protein Degradation Scientists exploit emerging technology and protein degradation tools for robust target validation experiments.


The successful candidate will contribute to the development of new drug targets by expanding our understanding of target biology and drug discovery. Working in close collaboration with other groups within the ICR, the candidate will develop our understanding of the therapeutic relevance of specific targets using genetic and pharmacologic approaches.

The successful candidate will be a part of a highly collaborative team that is embedded in the Centre for Cancer Drug Discovery. They will have the opportunity to direct their own research towards target identification, validation and drug discovery.

About you

Applicants must have a PhD in cell biology, cancer biology, genetics, or similar. Experience in drug discovery and modern cell and molecular biology techniques is essential. Experience with -omics level profiling and handling of large datasets is desired. Excellent organisational and communication skills are also required.

Candidates who are nearing completion of their PhD may apply, but confirmation on awarded PhD is required within 6 months of employment.

The ICR has a workforce agreement stating that Postdoctoral Training Fellows can only be employed for up to 7 years as PDTF at the ICR, providing total postdoctoral experience (including previous employment at this level elsewhere) does not exceed 7 years.

For general information on Postdocs at The ICR, more information can be found here.

 

Department/Directorate Information

About our organisation

We are one of the world’s most influential cancer research institutes with an outstanding record of achievement dating back more than 100 years. We are world leaders in identifying cancer genes, discovering cancer drugs and developing precision radiotherapy. Together with our hospital partner The Royal Marsden, we are rated in the top four centres for cancer research and treatment worldwide. As well as being a world-class institute, we are a college of the University of London. We came top in the league table of university research quality compiled from the Research Excellence Framework in 2014 and second in 2021. We have charitable status and rely on support from partner organisations, charities, donors and the general public. We have more than 1000 staff and postgraduate students across three sites – in Chelsea and Sutton.

 

About our Centre

The Centre for Cancer Drug Discovery (CCDD), within the Division of Cancer Therapeutics, is a multidisciplinary 'bench to bedside' centre, comprising around 160 staff dedicated to the discovery and development of novel therapeutics for the treatment of cancer. The CCDD’s exciting goal is to discover high quality drug candidates for validated biological targets and to progress these candidates to clinical trial. All the scientific disciplines are in place to make this possible. Our world-class biologists, chemists and drug metabolism specialists work together focusing on new molecular targets emerging from human genome and ground-breaking cell biology research. This is an exciting and fast-moving area of cancer research and offers the opportunity to work within a multi-disciplinary environment using state-of-the-art techniques and equipment.

 

Group information

Our group focus is to build robust target validation data packages against potential cancer targets identified by the ICR's researchers across Divisions. This is to increase confidence in the launch of drug discovery projects against those targets.
Our scientists collaborate with ICR researchers to expand on the target biology validation and build a strong therapeutic hypothesis for a target. Tractability of targets is assessed and the most appropriate therapeutic mode of action for a target will be defined. Research at the Centre for Target Validation is focused on applying best practice in target validation and implementing innovative technology to robustly validate targets for drug discovery.


Scientists in the CTV will form collaborations with ICR researchers who have identified potential therapeutic targets to:
Provide access to resources and core facilities to answer hypothesis-testing questions
Generate the key decision-making data required for target to enter drug discovery

The Centre for Target Validation therefore links the Centre for Cancer Drug Discovery within the Division of Cancer Therapeutics with partner Divisions that identify potential drug targets. The Centre is also in collaboration with the Division of Breast Cancer Research to validate targets relevant in breast cancer in the context of the Breast Cancer Now (BCN) Toby Robins Research Centre.

The CTV is supported and funded by the ICR as part of the ICR research strategy: Defeating Cancer to transform the lives of cancer patients.

Group Leader: Joanna Loizou
 

What we offer

  • A dynamic and supportive research environment
  • Access to state-of-the-art facilities and professional development opportunities
  • Collaboration with leading researchers in the field
  • Competitive salary and pension

We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Joanna Loizou via [email protected].

About The Institute of Cancer Research

Why work for us?

As a member of staff, you'll have exclusive access to a range of staff benefits.

The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.

The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here.

At the Institute of Cancer Research, we champion diversity as we believe it fuels innovation and drives impactful research. We welcome applicants from all walks of life, valuing diverse perspectives that enrich our work.

Don't let a checklist of qualifications hold you back – if you're passionate about the role, we want to hear from you. Your unique experiences and backgrounds contribute to the richness of our team. We are committed to being an equal opportunity for all, regardless of ethnicity, gender, age, sexual orientation, disability, or any other dimension of diversity. Join us in creating an inclusive environment where everyone's voice is heard and valued.

Other jobs like this

Location
Sutton
Position
Cancer Therapeutics
Salary Details:
From £45,600 per annum
Contract:
Fixed term
External Advertising End Date
18 May 2026
Location
Sutton
Position
Clinical Trials and Statistics Unit
Salary Details:
£38,891 - £45,144 per annum
Contract:
Fixed term
External Advertising End Date
10 May 2026
Location
Sutton
Position
Computational Imaging
Salary Details:
From £45,600 per annum
Contract:
Fixed term
External Advertising End Date
15 May 2026